Estradiol propoxyphenylpropionate
A synthetic estrogen used in hormone therapy
| Drug Information | |||
|---|---|---|---|
| Image | 
| ||
| Identifiers
ATC Code DrugBank UNII KEGG ChEBI ChEMBL |
Chemical Data
Molecular Weight | ||
Estradiol propoxyphenylpropionate is a synthetic estrogen used in hormone therapy for the treatment of menopausal symptoms, hypoestrogenism, and other conditions requiring estrogen supplementation. It is an ester of estradiol, the primary female sex hormone, and is designed to provide a prolonged release of estradiol when administered.
Pharmacology[edit | edit source]
Estradiol propoxyphenylpropionate is an ester prodrug of estradiol. Upon administration, it is slowly hydrolyzed in the body to release estradiol, which then exerts its effects by binding to and activating the estrogen receptor. This activation leads to the modulation of gene expression and the regulation of various physiological processes, including the maintenance of the female reproductive system, bone density, and cardiovascular health.
Medical Uses[edit | edit source]
Estradiol propoxyphenylpropionate is primarily used in hormone replacement therapy (HRT) for:
- Alleviating menopausal symptoms such as hot flashes, vaginal atrophy, and osteoporosis prevention.
- Treating hypoestrogenism due to hypogonadism, ovarian failure, or oophorectomy.
- Palliative treatment of certain types of breast cancer and prostate cancer.
Administration[edit | edit source]
The drug is typically administered via intramuscular injection, allowing for a slow and sustained release of estradiol into the bloodstream. The dosing regimen depends on the specific condition being treated and the patient's response to therapy.
Side Effects[edit | edit source]
Common side effects of estradiol propoxyphenylpropionate include:
Serious side effects may include:
- Increased risk of thromboembolic events
- Endometrial hyperplasia
- Breast cancer
Contraindications[edit | edit source]
Estradiol propoxyphenylpropionate is contraindicated in individuals with:
- Known or suspected breast cancer
- Active or history of thromboembolic disorders
- Liver dysfunction
- Known hypersensitivity to the drug
Also see[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
